C81.31
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Lymphocyte-depleted Hodgkin lymphoma is a rare and aggressive form of Hodgkin lymphoma, primarily affecting the lymph nodes of the head, face, and neck. This type is characterized by a significant reduction in lymphocytes, which are a type of white blood cell involved in the immune response. The condition typically impacts older adults and presents with noticeable swelling or lumps in the affected areas. Recognizing its complex nature is crucial for timely diagnosis and treatment planning.
Causes & Symptoms
Clinical Causes: The exact cause of lymphocyte-depleted Hodgkin lymphoma remains unknown. It is believed to result from genetic mutations that cause abnormal growth of lymphoid cells. Certain viral infections, such as Epstein-Barr virus (EBV), may play a role in its development. A weakened immune system, due to conditions like HIV/AIDS or immunosuppressive therapy, could increase risk. A history of other lymphoid or hematologic malignancies may also be linked.
Key Symptoms: Persistent swelling or lumps in the neck, face, or head area Unexplained weight loss Fever, often recurring or persistent Night sweats Fatigue or weakness Itching all over the body Difficulty swallowing or breathing if lymph nodes compress nearby structures
Diagnostic & Treatment
Diagnosis Path: Diagnosing lymphocyte-depleted Hodgkin lymphoma involves a combination of medical examinations and tests. Initially, physical examination focuses on swollen lymph nodes. Imaging studies, such as ultrasound, CT scans, or PET scans, help determine the extent and location of the disease. The definitive diagnosis requires a biopsy of affected lymph nodes, where microscopic analysis reveals characteristic Reed-Sternberg cells with specific features. Additional laboratory tests may include blood work to assess overall health and organ function. Staging tests are performed to determine the spread and severity of the lymphoma.
Treatment Protocols: Treatment strategies for lymphocyte-depleted Hodgkin lymphoma often involve a combination of therapies tailored to the disease stage and patient health. Chemotherapy remains the mainstay, typically involving aggressive regimens due to the disease's nature. Radiation therapy may be used in localized cases to target affected nodes. In some instances, stem cell transplantation could be considered for relapsed or refractory disease. Advances in targeted therapies and immunotherapy are promising options in ongoing research. Supportive care, including managing side effects and maintaining nutritional health, plays a vital role throughout treatment.
Clinical Advice & FAQs
Billing Guidance
Is C81.31 a billable ICD-10 code?
Yes, C81.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.31?
Clinical documentation must specify the nature of Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference